Skip to main content

Table 1 Patient characteristics and propensity score matching based on loading dose

From: Trends in teicoplanin loading dose implementation from 2010 to 2019 and evaluation of safety and efficacy factors: a retrospective cohort study based on a Japanese administrative claims database

 

Before propensity score matching

After propensity score matching

1,600 mg < 

(3,998)

 ≤ 1,600 mg

(6,032)

p value

1,600 mg < 

(3,309)

 ≤ 1,600 mg

(3,309)

SMD

Number of bedsa

  ≤ 199

181 (4.5)

596 (9.9)

 

180 (5.4)

184 (5.6)

 

 200–499

1,834 (45.9)

3,586 (59.4)

<0.001

1,727 (52.2)

1,731 (52.3)

0.007

  ≥ 500

1,983 (49.6)

1,850 (30.7)

 

1,402 (42.4)

1,394 (42.1)

 

CCI b

2 [1‒4]

2 [1‒4]

0.32

2 [1‒4]

2 [1‒4]

0.022

Age (years) b

75 [65‒83]

76 [67‒84]

 < 0.001

76 [66‒84]

75 [66‒83]

0.016

Weight b

54.8 [46.6‒63.8]

51.6 [43.6‒60.1]

 < 0.001

53.2 [45.4‒62.5]

53 [45‒62]

0.016

Reimbursementa

 Infection prevention and control premium

3,165 (79.2)

4,504 (74.7)

 < 0.001

2,601 (78.6)

2,585 (78.1)

0.012

 Inpatient pharmaceutical service premium

2,438 (61.0)

2,112 (35.0)

 < 0.001

1,762 (53.2)

1,802 (54.5)

0.024

Site of infectiona

 Respiratory infection

1,392 (34.8)

2,569 (42.6)

 < 0.001

1,278 (38.6)

1,246 (37.7)

0.020

 Bacteremia/sepsis

1,302 (32.6)

2,030 (33.7)

0.26

1,110 (33.5)

1,092 (33.0)

0.012

 Urinary tract infections

333 (8.3)

579 (9.6)

0.03

294 (8.9)

294 (8.9)

 < 0.001

 Intra-abdominal infections

276 (6.9)

318 (5.3)

0.001

194 (5.9)

201 (6.1)

0.009

 Skin and soft tissue infection

348 (8.7)

391 (6.5)

 < 0.001

274 (8.3)

267 (8.1)

0.008

 Bone and joint infections

337 (8.4)

336 (5.6)

 < 0.001

259 (7.8)

241 (7.3)

0.021

 Central nervous system infections

45 (1.1)

49 (0.8)

0.11

32 (1.0)

34 (1.0)

0.006

 Infective endocarditis

40 (1.0)

37 (0.6)

0.03

32 (1.0)

29 (0.9)

0.009

Clinical departmenta

 Internal medicine

827 (20.7)

2,037 (33.8)

 

806 (24.4)

839 (25.4)

 

 Hematology

385 (9.6)

912 (15.1)

 

354 (10.7)

372 (11.2)

 

 Surgery

456 (11.4)

695 (11.5)

 < 0.001

405 (12.2)

380 (11.5)

0.036

 Orthopedic surgery

410 (10.3)

449 (7.4)

 

316 (9.5)

316 (9.5)

 

 Others

1920 (48.0)

1,939 (32.1)

 

1,428 (43.2)

1,402 (42.4)

 
  1. CCI Charlson comorbidity index, SMD standardized mean difference
  2. aData are expressed n (%), and Chi-square test was performed for the significant difference test
  3. bData are expressed median [interquartile rate], and Mann–Whitney U test was performed for the significant difference test